180 Life Sciences - Warrants (07/11/2025) (ATNFW) has a PEG ratio of -0.0, below the Healthcare sector average of 11.64.
Get informed when a big investor buys or sells
+ Follow-0.00
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for ATNFW is -0.0. That is below the Healthcare sector average of 11.64. Investors often review this figure alongside 180 Life Sciences - Warrants (07/11/2025)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, ATNFW currently prints -0.0 for PEG ratio, while the sector average sits near 11.64. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at 180 Life Sciences - Warrants (07/11/2025)'s growth, margins, and balance sheet.
A PEG ratio of -0.0 for 180 Life Sciences - Warrants (07/11/2025) is not 'good' or 'bad' on its own. Compare it with the peer average (11.64) and with ATNFW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ATNFW's PEG ratio (-0.0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack 180 Life Sciences - Warrants (07/11/2025)'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.